ArticlePloS one2023

Screening fructosamine-3-kinase (FN3K) inhibitors, a deglycating enzyme of oncogenic Nrf2: Human FN3K homology modelling, docking and molecular dynamics simulations.

Narasimha M Beeraka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.